433 studies found for:    "Lupus"
Show Display Options
Rank Status Study
21 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
22 Active, not recruiting A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Interventions: Drug: corticosteroids;   Drug: cyclophosphamide;   Drug: mycophenolate mofetil;   Drug: ocrelizumab;   Drug: placebo
23 Completed
Has Results
Vitamin D3 in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   SLE;   Lupus
Interventions: Drug: Vitamin D3;   Drug: Vitamin D3 placebo
24 Enrolling by invitation European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Intervention: Procedure: laboratory analysis
25 Recruiting The Research Registry for Neonatal Lupus
Conditions: Neonatal Lupus;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Congenital Heart Block
Intervention: Other: No intervention; observational
26 Completed Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Conditions: Systemic Lupus Erythematosus;   Lupus
Interventions: Drug: pravastatin;   Drug: aspirin;   Drug: ramipril;   Drug: Vitamins: B6, B12, and folate;   Behavioral: heart health educational program
27 Completed To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: CC-11050
28 Terminated A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Condition: Discoid Lupus
Interventions: Drug: CC-930;   Drug: Placebo
29 Completed Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition: Discoid Lupus Erythematosus
Intervention: Drug: CC-10004
30 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
31 Completed Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis
Condition: Lupus Arthritis
Interventions: Drug: Laquinimod;   Other: Placebo
32 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
33 Withdrawn Velcade for Proliferative Lupus Nephritis
Conditions: Lupus Nephritis;   Proteinuria;   Hematuria
Intervention: Drug: Velcade
34 Withdrawn Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: prednisolone;   Drug: Placebo
35 Completed Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: laquinimod;   Drug: Mycophenolate Mofetil;   Drug: corticosteroids;   Drug: Placebo
36 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
37 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
38 Completed Lupus Nephritis: Role of Environmental and Occupational Exposures
Condition: Lupus Nephritis
Intervention:
39 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
40 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream applied twice daily;   Drug: Cream vehicle for ASF 1096 cream applied twice daily

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years